Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INSMED (INSM) EBITDA Margin: 2010-2014

Historic EBITDA Margin for INSMED (INSM) over the last 3 years, with Jun 2014 value amounting to 3,903.19%.

  • INSMED's EBITDA Margin rose 250886.00% to 3,903.19% in Q2 2014 from the same period last year, while for Jun 2014 it was 1,787.84%, marking a year-over-year decrease of 100151.00%. This contributed to the annual value of -478.39% for FY2013, which is 604038.00% down from last year.
  • INSMED's EBITDA Margin amounted to 3,903.19% in Q2 2014, which was up 65.43% from 2,359.41% recorded in Q1 2014.
  • In the past 5 years, INSMED's EBITDA Margin registered a high of 998,300.00% during Q2 2012, and its lowest value of -48.98% during Q2 2010.
  • Its 3-year average for EBITDA Margin is 153,268.69%, with a median of 3,208.00% in 2013.
  • Its EBITDA Margin has fluctuated over the past 5 years, first tumbled by 99,690,567bps in 2013, then surged by 250,886bps in 2014.
  • INSMED's EBITDA Margin (Quarterly) stood at -31.36% in 2010, then reached 4,213.06% in 2012, then tumbled by 100,506bps to 713.03% in 2013, then soared by 250,886bps to 3,903.19% in 2014.
  • Its EBITDA Margin was 3,903.19% in Q2 2014, compared to 2,359.41% in Q1 2014 and 713.03% in Q4 2013.